The Cystic Fibrosis Foundation is funding three new early-stage research awards worth more than $1.8 million to bolster the development…
Articles by Margarida Maia, PhD
Inadequate nutrition, poorly working or chronically infected lungs, and mutations leading to more severe disease can shorten the lifespan of…
Note: This story was updated Nov. 18, 2021, to correct information about Pulmozyme’s administration method. Bronchitol (mannitol) plus Pulmozyme…
The Cystic Fibrosis Foundation (CFF) is partnering with Pioneering Medicines, an initiative of Flagship Pioneering, to support the…
MRI scans may help to reveal subtle changes in certain areas of the brain among people with cystic fibrosis…
A Phase 1/2 clinical trial of an aerosol gene therapy candidate, 4D-710, in people with cystic fibrosis (CF) has been…
Pharmacy benefits and services company Elixir has chosen Maxor Specialty Pharmacy to be its network’s exclusive provider of medications for…
Poor bone density is increasingly evident in older cystic fibrosis (CF) patients, and may be linked to an inflammation…
Cystic fibrosis transmembrane conductance regulator (CFTR), the protein that is mutated in cystic fibrosis (CF), is not as rigid…
Kaftrio, marketed as Trikafta in the U.S., may be effective in people with cystic fibrosis (CF) who have…